Dr. Alwyn Mwinga, Chief Executive Officer
Dr. Alwyn Mwinga is a physician trained at the University of Zambia and the University of London. Following her postgraduate training at the London School of Hygiene and Tropical Medicine (LSHTM), she spent 10 years working in TB/HIV research. She has served on several national and international boards on various HIV/TB activities and has been instrumental in the development of National TB control and prevention programmes.
In recognition of her contributions to TB and HIV, she was awarded a Global Health Achievement award by the CDC’s Office of Global Health in 2007 and the PEPFAR Lifetime Achievement award by the US Office of the Global AIDS Coordinator in 2011. After 12 years working in public health, Dr. Mwinga returned to the field of research and is now Zambart’s Chief Executive Officer since May 2013.
She guides Zambart’s vision and strategic direction, and helps to shape and approve the organisation’s strategies and advocates for the organisations key objectives and issues.
Dr. Helen Ayles, Research Director
Dr Helen Ayles was trained as a physician in London where she specialized in infectious and tropical diseases. She has a PhD in Epidemiology from the London School of Hygiene and Tropical Medicine. She has worked as a clinician in the UK, Uganda and Zambia, and has over 15 years of developing country experience in clinical TB/HIV management and epidemiology.
Dr. Ayles is the research director at Zambart, which has conducted research into the dual TB/HIV epidemic in Zambia for over 20 years and has over 600 staff working on different studies. She is also a senior lecturer in the clinical research unit at the London school of Hygiene and Tropical Medicine (LSHTM), and technical advisor on national TB/HIV and MDR-TB working groups, and national TB review team.
Dr. Virginia (Ginny) Bond, Director
Virginia (Ginny) Bond is a Director at Zambart since 2004 and heads the Social Science Unit. She is a social anthropologist, pursuing mixed methods and interdisciplinary approaches to both urgent public health and social issues. Her areas of expertise are the ethnographies of the TB and HIV epidemics in Zambia and South Africa since the early 1990s (including the role of children and the convergence of the dual epidemics with food insecurity), health related stigma and the influence of local contexts on the uptake of public health interventions. Her current research portfolio includes being the lead social scientist in two community randomised trials – HPTN 071/PopART and the Better Health Outcomes through Mentoring and Assessment (BHOMA) – and a principal collaborator of a qualitative study of HIV, disability and HIV treatment.
She does face-to-face and distance learning teaching at London School of Hygiene and Tropical Medicine (LSHTM) and supervises PhD and Masters students from a number of institutions. She is committed to developing Zambian social science capacity in the field of public health.
Dr. Peter Godfrey-Fausset, Director
Dr. Peter Godfrey-Faussett is the founder member of Zambart and a member of its board. After training in infectious diseases and molecular genetics, he led the organisation in its formative years. He was co-Principal Investigator (PI) on the ZAMSTAR study, the largest study ever conducted to study methods of reducing Tuberculosis prevalence and community level, and also one of Zambart’s large scale community-randomised clinical trials on TB and HIV.
Dr. Godfrey-Faussett is professor of Infectious Diseases and International Health at the London School of Hygiene and Tropical Medicine (LSHTM), and consultant physician at the Hospital for Tropical Diseases. Currently, he is seconded full-time to UNAIDS, where he is the Senior Science Adviser with a wide ranging portfolio including HIV cure, ARV-based HIV prevention, HIV vaccines and synergies between the HIV and the non-communicable disease response.